Ipilimumab/nivolumabAutoimmune hypophysitis

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1985卷 / 1期

关键词：

D O I：

10.1007/s40278-023-51041-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：271 / 271

相关论文

共 50 条

[31] Ipilimumab/nivolumabAutoimmune disorders and exanthema: case report
Reactions Weekly, 2019, 1754 (1) : 201 - 201
[32] Ipilimumab/nivolumabAutoimmune hepatitis and autoimmune thyroiditis: case report
Reactions Weekly, 2017, 1665 (1) : 162 - 162
[33] IPILIMUMAB-INDUCED SECONDARY HYPOPHYSITIS
Cheema, Arvinder
ENDOCRINE PRACTICE, 2018, 24 (09) : 854 - 854
[34] Ipilimumab/prednisoneLymphocytic hypophysitis: case report
Reactions Weekly, 2018, 1712 (1) : 315 - 315
[35] Ipilimumab (Immune Checkpoint Inhibitors) Hypophysitis
Stagnetto, Margot
Mailleux, Patrick
JOURNAL OF THE BELGIAN SOCIETY OF RADIOLOGY, 2020, 104 (01):
[36] Ipilimumab/nivolumabThyroiditis and hypophysitis: case report
Reactions Weekly, 2022, 1900 (1) : 178 - 178
[37] Hypophysitis under Ipilimumab? Indeed Neuroborreliosis
Baltzer, A.
Forkel, S.
Brehmer, F.
Schoen, M. P.
Kretschmer, L.
Kai, T.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2015, 13 : 43 - 43
[38] Ipilimumab/nivolumabHyponatraemia and hypophysitis: case report
Reactions Weekly, 2024, 2037 (1) : 218 - 218
[39] Ipilimumab/prednisoneLymphocytic hypophysitis: case report
Reactions Weekly, 2018, 1714 (1) : 243 - 243
[40] Ipilimumab/nivolumabAutoimmune demyelinating polyneuropathy and myasthenia gravis: case report
Reactions Weekly, 2022, 1917 (1) : 322 - 322

← 1 2 3 4 5 →